1. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: IDF;2021.
2. de Jong M, Woodward M, Peters SA. Diabetes, glycated hemoglobin, and the risk of myocardial infarction in women and men: a prospective cohort study of the UK biobank. Diabetes Care. 2020; 43:2050–9.

3. Vryonidou A, Paschou SA, Muscogiuri G, Orio F, Goulis DG. Mechanisms in endocrinology: metabolic syndrome through the female life cycle. Eur J Endocrinol. 2015; 173:R153–63.

4. Landon MB, Galan HL, Jauniaux ERM, Driscoll DA, Berghella V, Grobman WA, et al. Gabbe’s obstetrics: normal and problem pregnancies. 8th ed. Philadelphia: Elsevier;2020.
5. Shi M, Zhou X, Zheng C, Pan Y. The association between parity and metabolic syndrome and its components in normal-weight postmenopausal women in China. BMC Endocr Disord. 2021; 21:8.

6. Mueller NT, Mueller NJ, Odegaard AO, Gross MD, Koh WP, Yuan JM, et al. Higher parity is associated with an increased risk of type-II diabetes in Chinese women: the Singapore Chinese Health Study. BJOG. 2013; 120:1483–9.

7. Fowler-Brown AG, de Boer IH, Catov JM, Carnethon MR, Kamineni A, Kuller LH, et al. Parity and the association with diabetes in older women. Diabetes Care. 2010; 33:1778–82.

8. Nicholson WK, Asao K, Brancati F, Coresh J, Pankow JS, Powe NR. Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2006; 29:2349–54.
9. Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality. Pharmacogenomics. 2005; 6:639–46.

10. Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015; 12:e1001779.

11. Zoet GA, Paauw ND, Groenhof K, Franx A, Gansevoort RT, Groen H, et al. Association between parity and persistent weight gain at age 40-60 years: a longitudinal prospective cohort study. BMJ Open. 2019; 9:e024279.
12. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016; 133:187–225.

13. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363:157–63.
14. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120:1640–5.
15. Zhang YB, Chen C, Pan XF, Guo J, Li Y, Franco OH, et al. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ. 2021; 373:n604.

16. Lee SN, Yun JS, Ko SH, Ahn YB, Yoo KD, Her SH, et al. Impacts of gender and lifestyle on the association between depressive symptoms and cardiovascular disease risk in the UK Biobank. Sci Rep. 2023; 13:10758.

17. Elliott P, Peakman TC; UK Biobank. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008; 37:234–44.

18. Ge T, Chen CY, Ni Y, Feng YA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019; 10:1776.

19. Scott RA, Scott LJ, Magi R, Marullo L, Gaulton KJ, Kaakinen M, et al. An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes. 2017; 66:2888–902.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81:559–75.

21. Peters SA, Woodward M. Women’s reproductive factors and incident cardiovascular disease in the UK Biobank. Heart. 2018; 104:1069–75.

22. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA. 2005; 294:2751–7.

23. Moon JH, Lee J, Kim KH, Kim HJ, Kim H, Cha HN, et al. Multiparity increases the risk of diabetes by impairing the proliferative capacity of pancreatic β cells. Exp Mol Med. 2023; 55:2269–80.

24. Fang H, Li Q, Wang H, Ren Y, Zhang L, Yang L. Maternal nutrient metabolism in the liver during pregnancy. Front Endocrinol (Lausanne). 2024; 15:1295677.

25. Rebholz SL, Jones T, Burke KT, Jaeschke A, Tso P, D’Alessio DA, et al. Multiparity leads to obesity and inflammation in mothers and obesity in male offspring. Am J Physiol Endocrinol Metab. 2012; 302:E449–57.

26. Williamson DF, Madans J, Pamuk E, Flegal KM, Kendrick JS, Serdula MK. A prospective study of childbearing and 10-year weight gain in US white women 25 to 45 years of age. Int J Obes Relat Metab Disord. 1994; 18:561–9.
27. Smith DE, Lewis CE, Caveny JL, Perkins LL, Burke GL, Bild DE. Longitudinal changes in adiposity associated with pregnancy. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study. JAMA. 1994; 271:1747–51.

28. Kac G, Benicio MH, Velasquez-Melendez G, Valente JG, Struchiner CJ. Gestational weight gain and prepregnancy weight influence postpartum weight retention in a cohort of brazilian women. J Nutr. 2004; 134:661–6.

29. Sun MH, Wen ZY, Wang R, Gao C, Yin JL, Chang YJ, et al. Parity and metabolic syndrome risk: a systematic review and meta-analysis of 15 observational studies with 62,095 women. Front Med (Lausanne). 2022; 9:926944.

30. Li P, Shan Z, Zhou L, Xie M, Bao W, Zhang Y, et al. Mechanisms in endocrinology: parity and risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Endocrinol. 2016; 175:R231–45.

31. Iversen DS, Stoy J, Kampmann U, Voss TS, Madsen LR, Moller N, et al. Parity and type 2 diabetes mellitus: a study of insulin resistance and β-cell function in women with multiple pregnancies. BMJ Open Diabetes Res Care. 2016; 4:e000237.

32. Araneta MR, Barrett-Connor E. Grand multiparity is associated with type 2 diabetes in Filipino American women, independent of visceral fat and adiponectin. Diabetes Care. 2010; 33:385–9.

33. Beyerlein A, Lack N, von Kries R. Within-population average ranges compared with Institute of Medicine recommendations for gestational weight gain. Obstet Gynecol. 2010; 116:1111–8.

34. Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach. Obes Rev. 2007; 8:3–10.
35. Siega-Riz AM, Herring AH, Carrier K, Evenson KR, Dole N, Deierlein A. Sociodemographic, perinatal, behavioral, and psychosocial predictors of weight retention at 3 and 12 months postpartum. Obesity (Silver Spring). 2010; 18:1996–2003.

36. Makama M, Earnest A, Lim S, Skouteris H, Hill B, Teede H, et al. Assessing patterns of change in lifestyle behaviours by parity: a longitudinal cohort study. Int J Epidemiol. 2023; 52:589–99.

37. Li W, Wang Y, Shen L, Song L, Li H, Liu B, et al. Association between parity and obesity patterns in a middle-aged and older Chinese population: a cross-sectional analysis in the TongjiDongfeng cohort study. Nutr Metab (Lond). 2016; 13:72.

38. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000; 106:473–81.

39. Cho YM. Incretin physiology and pathophysiology from an Asian perspective. J Diabetes Investig. 2015; 6:495–507.
40. Williams R, Periasamy M. Genetic and environmental factors contributing to visceral adiposity in Asian populations. Endocrinol Metab (Seoul). 2020; 35:681–95.

41. Gunderson EP, Sternfeld B, Wellons MF, Whitmer RA, Chiang V, Quesenberry CP Jr, et al. Childbearing may increase visceral adipose tissue independent of overall increase in body fat. Obesity (Silver Spring). 2008; 16:1078–84.

42. Yabe D, Seino Y, Fukushima M, Seino S. β Cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr Diab Rep. 2015; 15:602.

43. Kinnunen TI, Waage CW, Sommer C, Sletner L, Raitanen J, Jenum AK. Ethnic differences in gestational weight gain: a population-based cohort study in Norway. Matern Child Health J. 2016; 20:1485–96.

44. Naver KV, Lundbye-Christensen S, Gorst-Rasmussen A, Nilas L, Secher NJ, Rasmussen S, et al. Parity and risk of diabetes in a Danish nationwide birth cohort. Diabet Med. 2011; 28:43–7.

45. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008; 31:2383–90.

46. Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med. 2017; 15:131.

47. Davis KA, Coleman JR, Adams M, Allen N, Breen G, Cullen B, et al. Mental health in UK Biobank: development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysis. BJPsych Open. 2020; 6:e18.

48. Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 2015; 104:30–7.

49. Horta BL, de Lima NP. Breastfeeding and type 2 diabetes: systematic review and meta-analysis. Curr Diab Rep. 2019; 19:1.

50. Marinho FS, Moram CB, Rodrigues PC, Leite NC, Salles GF, Cardoso CR. Treatment adherence and its associated factors in patients with type 2 diabetes: results from the Rio de Janeiro type 2 diabetes cohort study. J Diabetes Res. 2018; 2018:8970196.
